Clinical Trial Update: Surveillance of Humira in Korean JIA Patients

View source ↗

Summary

A post-marketing safety surveillance study of Humira (adalimumab) in Korean patients with polyarticular juvenile idiopathic arthritis has completed. Results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polyarticular Juvenile Idiopathic Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie | Conditions: Polyarticular Juvenile Idiopathic Arthritis | Status: COMPLETED | Results posted: 2017-06-23